Medpace Q3 earnings released; Board authorizes $500M share buyback

Medpace Holdings, Inc.

Board authorized share repurchases of up to $500M of common stock on Oct 21, 2022.
Repurchases at management's discretion with no minimum obligation.
Q3 2022 financial results press released on Oct 24; specific numbers not included in this filing.

item 2.02 item 8.01 item 9.01

Medpace Holdings, Inc. filing history →

Source: SEC EDGAR

accession 0001668397-22-000006

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.